Gilead Fights Chinese Research Institute Over COVID Patent
American biopharmaceutical company Gilead is asking a London court to ax a Chinese military research institute's patent for a COVID-19 treatment, arguing that the drug was not a patentable invention....To view the full article, register now.
Already a subscriber? Click here to view full article